Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Glimepiride;   Drug: Metformin;   Drug: Pioglitazone;   Drug: Acarbose;   Drug: Linagliptin;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Insulin Glargine;   Drug: Exenatide once weekly (QW);   Drug: Exenatide twice daily (BID)
Sponsor:   Eli Lilly and Company
Not yet recruiting - verified February 2014

Condition:   Type 2 Diabetes Mellitus
Intervention:   Drug: Pioglitazone
Sponsor:   Takeda
Active, not recruiting - verified February 2014

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Metformin;   Drug: Pioglitazone
Sponsor:   Tehran University of Medical Sciences
Completed - verified January 2014

Condition:   Type 2 Diabetes Mellitus
Intervention:   Drug: Pioglitazone/metformin hydrochloride
Sponsor:   Takeda
Completed - verified December 2013

Condition:   Type 2 Diabetes Mellitus
Intervention:   Drug: Pioglitazone
Sponsor:   Takeda
Completed - verified December 2013

Condition:   Type 2 Diabetes Mellitus
Intervention:   Drug: Pioglitazone
Sponsor:   Takeda
Completed - verified December 2013

Condition:   Type 2 Diabetes Mellitus
Intervention:   Drug: Alogliptin/pioglitazone
Sponsor:   Takeda
Active, not recruiting - verified November 2013

Condition:   Type II Diabetes Mellitus
Interventions:   Drug: Pioglitazone;   Drug: Metformin;   Drug: Sulfonylurea
Sponsor:   Takeda
Not yet recruiting - verified October 2013

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Metformin;   Drug: Pioglitazone
Sponsors:   Tehran University of Medical Sciences;   Tehran University of Medical Sciences
Completed - verified October 2013

Conditions:   LVM;   Type 2 Diabetic Patients With IHD;   Endothelial Function
Interventions:   Drug: pioglitazone group;   Drug: Metformin group
Sponsors:   Wuhan General Hospital of Guangzhou Military Command;   Xiang Guang-da
Not yet recruiting - verified August 2013

Conditions:   Diabetes Mellitus;   Diabetes Mellitus, Type 2;   Glucose Metabolism Disorders
Interventions:   Drug: Pioglitazone;   Drug: Metformin
Sponsors:   King Abdulaziz University;   King Abdulaziz University
Active, not recruiting - verified September 2013

Condition:   Mild Cognitive Impairment Due to Alzheimer's Disease
Interventions:   Drug: Pioglitazone;   Drug: Pioglitazone placebo
Sponsors:   Takeda;   Takeda;   Zinfandel Pharmaceuticals
Not yet recruiting - verified August 2013

Conditions:   Castration Resistant Prostate Cancer (CRPC);   Pharmacokinetics of MDV3100
Interventions:   Drug: MDV3100;   Drug: Pioglitazone;   Drug: Warfarin;   Drug: Omeprazole;   Drug: Midazolam
Sponsors:   Astellas Pharma Inc;   Astellas Pharma Europe BV;   Medivation, Inc.
Completed - verified July 2013

Conditions:   Polycystic Ovary Syndrome;   Infertility
Interventions:   Drug: induction of ovulation using letrozole-pioglitazone-metformin;   Drug: induction of ovulation using clomiphene citrate-pioglitazone-metformin;   Radiation: transvaginal ultrasound;   Other: body mass index (BMI) calculation;   Other: day 3: follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), total testosterone;   Other: pretreatment blood urea and serum creatinine;   Other: serum estradiol (E2) on day 12;   Other: serum progesterone on day 21;   Other: blood urea and serum creatinine every month
Sponsors:   Cairo University;   Cairo University
Not yet recruiting - verified July 2013

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Metformin;   Drug: Pioglitazone;   Drug: Sitagliptin
Sponsors:   University of Pavia;   University of Pavia;   IRCCS Policlinico S. Matteo
Recruiting - verified July 2013

Condition:   Healthy Volunteers
Interventions:   Drug: Pioglitazone HCl;   Drug: Abiraterone acetate
Sponsors:   Janssen Research & Development, LLC;   Janssen Research & Development, LLC
Recruiting - verified June 2013

Condition:   Cancer of the Pancreas
Intervention:   Drug: Pioglitazone
Sponsors:   University of Texas Southwestern Medical Center;   University of Texas Southwestern Medical Center
Not yet recruiting - verified February 2013

Condition:   To Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT Imaging
Intervention:   Drug: Pioglitazone vs Glimepiride
Sponsors:   Kurume University;   Kurume University
Recruiting - verified March 2013

Conditions:   Infertility, Female;   Obesity
Interventions:   Other: Microdialysis;   Dietary Supplement: Vascepa - Fish Oil;   Drug: Aspirin;   Drug: Pioglitazone
Sponsors:   University of Colorado, Denver;   University of Colorado, Denver;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2013

Condition:   Healthy
Intervention:   Drug: Torrent's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets
Sponsors:   Torrent Pharmaceuticals Limited;   Torrent Pharmaceuticals Limited
Completed - verified February 2013